Cognyte Software Ltd. logo
Cognyte Software Ltd. CGNT
$ 8.78 0.57%

Annual report 2025
added 03-21-2026

report update icon

Cognyte Software Ltd. Balance Sheet 2011-2026 | CGNT

Annual Balance Sheet Cognyte Software Ltd.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-47.4 M - - - -20.7 M -8.96 M 13.3 M 21.2 M 16.3 M 7.51 M -9.04 M

Long Term Debt

- - - - 24.1 M - - - - - 22.5 M 22.4 M 17 M 10 M -

Long Term Debt Current

- - - - 7.08 M - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - 1.33 M 1.23 M 23.8 M 22.5 M 17.1 M 10.1 M 5.08 M

Total Current Liabilities

219 M 190 M 194 M 320 M 299 M 280 M - - - - - - - - -

Total Liabilities

281 M 257 M 233 M 366 M 358 M 350 M - - 10.7 M 10.1 M 34 M 25.3 M 20 M 13 M 13.2 M

Deferred Revenue

- - - - 127 M - - - 775 K 598 K - 210 K 130 K 672 K 5.69 M

Retained Earnings

-157 M -145 M -129 M -14.9 M - - - - -82 M -81 M -51.9 M -118 M -110 M -99.3 M -88.3 M

Total Assets

498 M 472 M 443 M 665 M 629 M 805 M - - 74.7 M 73.4 M 56.8 M 10.8 M 11.4 M 12.6 M 19.8 M

Cash and Cash Equivalents

- - - - 78.6 M 201 M 283 M - - - - - - - -

Book Value

217 M 215 M 210 M 299 M 270 M 455 M - - 64 M 63.2 M 22.7 M -14.5 M -8.6 M -449 K 6.52 M

Total Shareholders Equity

198 M 198 M 210 M 299 M 270 M 455 M 475 M - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Cognyte Software Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

17.2 M - - - - - - - 2.51 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

366 M - - - 358 M - - - 350 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

83.2 M - - - 127 M - - - 144 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

665 M - - - 629 M - - - 805 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

153 M - - - 78.6 M - - - 201 M - - - 240 M - - - 292 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

299 M - - - 270 M - - - 455 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

285 M - - - 258 M - - - 445 M - - - 475 M - - - 431 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Cognyte Software Ltd., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.9 -1.45 % $ 1.61 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 8.95 -4.64 % $ 253 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 36.56 -0.49 % $ 5.45 K usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.59 -0.08 % $ 122 M usaUSA
Myomo Myomo
MYO
$ 0.66 -5.54 % $ 27.6 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.42 -1.16 % $ 128 M franceFrance
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Align Technology Align Technology
ALGN
$ 167.26 -2.69 % $ 12.5 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 30.8 -5.64 % $ 1.42 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Globus Medical Globus Medical
GMED
$ 89.86 1.39 % $ 12.2 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Butterfly Network Butterfly Network
BFLY
$ 4.02 -2.9 % $ 851 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.58 -1.27 % $ 36.1 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.64 -0.62 % $ 345 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 61.81 -1.2 % $ 91.5 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 10.98 0.05 % $ 1.65 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 34.7 1.86 % $ 1.08 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.82 -4.21 % $ 1.11 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.25 -0.64 % $ 712 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 80.79 -0.44 % $ 47.2 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.03 3.61 % $ 17.4 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 84.62 -1.17 % $ 2.94 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 53.48 -1.19 % $ 1.57 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.69 -1.57 % $ 368 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
LENSAR LENSAR
LNSR
$ 5.58 -5.26 % $ 66.7 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 86.63 0.39 % $ 111 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.68 -0.76 % $ 463 M curacaoCuracao
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA